LIDDS — Lidds AB Share Price
- SEK11.26m
- -SEK2.25m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.81 | ||
Price to Tang. Book | 0.93 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | n/a | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -292.64% | ||
Return on Equity | -274.93% | ||
Operating Margin | n/a |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | SEKm | n/a | 0.34 | 3.55 | 1.89 | n/a | n/a | n/a | -100% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Lidds AB (LIDDS) is a Sweden-based company engaged in the development of pharmaceutical products. LIDDS (Local Intelligent Drug Delivery System) uses its drug delivery technology, a parenteral, microparticulate drug carrier matrix, which is administered as a paste that spreads in the tissue and ultimately cures shortly after injection, allowing local treatment at site of disease. It targets primarily solid tumors. The Company’s portfolio includes Liproca Depot, aimed at prostate cancer with possible applications in benign prostate hypertrophy (BPH). The Liproca Depot is a bioresorbable, biocompatible and locally injectable modified release formulation of 2-hydroxyflutamid, prepared as a paste prior to injection.
Directors
- Jan Tornell CHM (57)
- Nina Herne CEO
- Jenni Bjornulfson CFO
- Markus Thor VBD (48)
- Niklas Axen OTH (53)
- Charlotta Gauffin OTH
- Carl-Gustaf Golander OTH (63)
- Stefan Gruden OTH (44)
- Anna Torner OTH
- David Bejker DRC (46)
- Anders Bjartell DRC (57)
- Ingalill Forslund Larsson DRC (65)
- Maria Forss DRC (49)
- Daniel Lifveredson DRC
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- November 30th, 1999
- Public Since
- July 31st, 2014
- No. of Employees
- 2
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 68,231,663
- Address
- Virdings Alle 32 B, UPPSALA, 754 50
- Web
- https://liddspharma.com/
- Phone
- +46 42387427
- Auditors
- Ohrlings PricewaterhouseCoopers AB
Upcoming Events for LIDDS
Q1 2024 Lidds AB Earnings Release
Lidds AB Annual Shareholders Meeting
Q2 2024 Lidds AB Earnings Release
Similar to LIDDS
2cureX AB
OMX Nordic Exchange Stockholm
Abliva AB
OMX Nordic Exchange Stockholm
Acousort AB
OMX Nordic Exchange Stockholm
Active Biotech AB publ
OMX Nordic Exchange Stockholm
AddLife AB
OMX Nordic Exchange Stockholm
FAQ
As of Today at 18:13 UTC, shares in Lidds AB are trading at SEK0.17. This share price information is delayed by 15 minutes.
Shares in Lidds AB last closed at SEK0.17 and the price had moved by -88.36% over the past 365 days. In terms of relative price strength the Lidds AB share price has underperformed the FTSE Global All Cap Index by -89.96% over the past year.
There is no consensus recommendation for this security.
Lidds AB does not currently pay a dividend.
Lidds AB does not currently pay a dividend.
Lidds AB does not currently pay a dividend.
To buy shares in Lidds AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK0.17, shares in Lidds AB had a market capitalisation of SEK11.26m.
Here are the trading details for Lidds AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: LIDDS
Based on an overall assessment of its quality, value and momentum Lidds AB is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Lidds AB is SEK4.30. That is 2506.06% above the last closing price of SEK0.17.
Analysts covering Lidds AB currently have a consensus Earnings Per Share (EPS) forecast of -SEK0.50 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Lidds AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -41.45%.
As of the last closing price of SEK0.17, shares in Lidds AB were trading -36.83% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Lidds AB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK0.17.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Lidds AB's management team is headed by:
- Jan Tornell - CHM
- Nina Herne - CEO
- Jenni Bjornulfson - CFO
- Markus Thor - VBD
- Niklas Axen - OTH
- Charlotta Gauffin - OTH
- Carl-Gustaf Golander - OTH
- Stefan Gruden - OTH
- Anna Torner - OTH
- David Bejker - DRC
- Anders Bjartell - DRC
- Ingalill Forslund Larsson - DRC
- Maria Forss - DRC
- Daniel Lifveredson - DRC